Clin Osteol 2017; 22(4): 128-135
Bone mineral density changes in patients with diabetes mellitus -are the measurements sufficient to assess at-risk patients?Original contributions
Introduction: Osteoporosis is an increasingly widespread disease, and so is diabetes mellitus. It is now accepted that osteoporotic fractures are a serious co-morbidity and complication of diabetes. The risk of fracture is elevated in patients with type 1 diabetes (T1DM) in whom bone mineral density (BMD) is reduced as well as in type 2 diabetes (T2DM) patients with normal bone mineral density.
Objective: To determine BMD changes in patients with T1DM and T2DM, and to compare them with a control group without diabetes.
Patients and methods: A cohort of postmenopausal women with diabetes and a matched control group were analyzed. The cohort consisted of 145 women, of whom 76 had diabetes mellitus (25 T1DM, 51 T2DM) and 69 had no glucose metabolism impairment. For all patients, central BMD (lumbar spine [LS] and hip) was tested by DXA, glycemic control parameters were assessed, and anthropometric parameters were measured. Bone quality was analyzed using the TBS software and the results were statistically processed.
Results: In T1DM, BMD was significantly (p = 0.01) lower than in the control group (LS: 0.71 ? 0.13 g/cm2 vs. 0.98 ? 0.13 g/cm2; hip: 0.61 ? 0.10 g/cm2 vs. 0.81 ? 0.13 g/cm2). Patients with T2DM had a higher BMD than patients with T1DM (LS: 0.91 ? 0.16 g/cm2 vs. 0.71 ? 0.13 g/cm2; hip: 0.79 ? 0.17 g/cm2 vs. 0.61 ? 0.13 g/cm2). There was no significant difference in BMD between T2DM patients and controls. Patients with T1DM had a higher incidence of osteoporosis than T2DM patients (35 % vs. 11 %). Up to 76 % of T2DM patients had osteopenia. In the control group, as many as 65 % of patients had neither osteoporosis nor osteopenia, 32 % had osteopenia and 3 % had osteoporosis.
Conclusion: Postmenopausal women with T1DM were confirmed to have significantly reduced BMD compared to controls. Patients with T2DM had higher BMD than T1DM in whom the levels were comparable to those in the non-diabetic population. This fact makes identification of T2DM patients at risk for osteoporotic fractures difficult. Therefore, other modalities are discussed in clinical practice that would improve assessment of the risk for osteoporosis in T2DM. One of them is a combination of densitometry and trabecular bone score.
Keywords: osteoporosis, diabetes mellitus, fractures, bone quality, glycemic compensation
Published: December 11, 2017 Show citation
References
- Kurra S, Siris E. Diabetes and bone health: the relationship bet diabetes and osteoporosis-associated fractures. Diabetes/Metabolism Research and Reviews 2011;27(5):430-435.
Go to original source... - Jackuliak P, Payer J. Osteoporosis, Fractures, and Diabetes. In tional Journal of Endocrinology 2014;2014:10.
Go to original source... - Nazrun AS, Tzar MN, Mokhtar SA, Mohamed IN. A systematic review of the outcomes of osteoporotic fracture patients after hospital disch ge: morbidity, subsequent fractures, and mortality. Therapeutics and Clinical Risk Management 2014;10:937-948.
Go to original source... - Ferrari S. Diabetes and Bone. Calcified tissue international 2017; 100(2):107-108.
Go to original source... - Carnevale V, Romagnoli E, D'Erasmo E. Skeletal involvement in pati ents with diabetes mellitus. Diabetes/Metabolism Research and Reviews 2004;20(3):196-204.
Go to original source... - Hingorani A, LaMuraglia GM, Henke P, Meissner MH, Loretz L, Zinszer KM et al. The management of diabetic foot: A clinical practi ce guideline by the Society for Vascular Surgery in collaboration with the American Podiatric Medical Association and the Society for Vascular Medicine. Journal of Vascular Surgery 2016;63(2):3S-21S.
Go to original source... - Vestergaard P, Rejnmark L, Mosekilde L. Diabetes and its complica tions and their relationship with risk of fractures i tes. Calcified tissue international 2009;84(1):45-55.
Go to original source... - Dytfeld J, Michalak M. Type 2 diabetes and risk of low-energy fra res in postmenopausal women: meta-analysis of observational studies. Aging clinical and experimental research 2017;29(2):301-309.
Go to original source... - The International Society for Clini Positions 2015 for Adults. 2015. p 17.
- Jackuliak P. Základné princípy osteoporózy. In: Payer J, Borovs editors. Osteoporóza u vybranných ochorení. Bratislava: Herba 2014; s. 11-42.
- American Diabetes Association Standards of Medical Care in Diabe 2015: Classification and Diagnosis of Diabetes. Diabetes Care 2015; p S8-S16.
Go to original source... - DCCT. The Diabetes Control Complications Trial Research Group: The Effect of Intensive Treatment of Diabetes on the Development and Progression of Long-Term Complications in Insulin-Dependent Diabetes Mellitus. New England Journal of Medicine 1993;329(14): 977-986.
Go to original source... - Rohlfing CL, Wiedmeyer HM, Little RR, England JD, Tennill A, Goldstein DE. Defining the relationship between plasma glucose and HbA(1c): analysis of glucose profiles and HbA(1c) in the Diabetes Control and Complications Trial. Diabetes Care 2002;25(2):275-278.
Go to original source... - Pscherer S, Kostev K, Dippel FW, Rathmann W. Fracture risk in pa tients with type 2 diabetes under different antidiabetic treatment mens: a retrospective database analysis in primary care. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2016;9:17-23.
Go to original source... - Starup-Linde J, Vestergaard P. Diabetes and osteoporosis: concern? European Journal of Endocrinology 2015;173(3):R93-R9.
Go to original source... - Johnell O, Kanis JA, Oden A, Johansson H, De Laet C, Delmas P et Predictive Value of BMD for Hip and Other Fractures. Journal of Bone and Mineral Research 2005;20(7):1185-1194.
Go to original source... - Melton LJ, Leibson CL, Achenbach SJ, Therneau TM, Khosla S. Fracture risk in type 2 diabetes: update of a population-based study. J Bone Miner Res 2008;23(8):1334-1342.
Go to original source... - Jackuliak P, Payer J. Fracture risk in type 2 diabetes and trabecul ne score. Diabetes 2014;63(Suppl. 1):A380.
- Compston JE, Watts NB, Chapurlat R, Cooper C, Boonen S, Greenspan S et al. Obesity is Not Protective Against Fracture in Post menopausal Women: GLOW. The American journal of medicine 2011; 124(11):1043-1050.
Go to original source... - Compston JE, Flahive J, Hosmer DW, Watts NB, Siris ES, Silverman S et al. Relationship of Weight, Height, and Body Mass Index with Fracture Risk at Different Sites in Postmenopausal Women: The Global Longitudinal study of Osteoporosis in Women (GLOW). Journal of bo ne and mineral research : the official journal of the American Society for Bone and Mineral Research 2014;29(2):487-493.
Go to original source... - Schwartz AV, Vittinghoff E, Bauer DC, Hillier TA, Strotmeyer ES, Ensrud KE et al. Association of BMD and FRAX Score with Risk of Fracture in Older Adults with Type 2 Diabetes. JAMA 2011;305(21): 2184-2192.
Go to original source... - Giangregorio LM, Leslie WD, Lix LM, Johansson H, Oden A, McCloskey E et al. FRAX underestimates fracture risk in patients with diabetes. J Bone Miner Res 2012;27(2):301-308.
Go to original source... - Leslie WD, Morin SN, Lix LM, Majumdar SR. Does diabetes modify the effect of FRAX risk factors for predicting major osteoporotic and hip fracture? Osteoporos Int 2014;25(12):2817-2824.
Go to original source... - Russo GT, Giandalia A, Romeo EL, Nunziata M, Muscianisi M, Ruffo MC et al. Fracture Risk in Type 2 Diabetes: Current Perspectives and Gender Differences. International Journal of Endocrinology 2016; 2016:1615735.
Go to original source... - Kanis JA, Oden A, Johnell O, Johansson H, De Laet C, Brown J et al. The use of clinical risk factors enhances the performance of BMD in the prediction of hip and osteoporotic fractures in men and women. Osteoporos Int 2007;18(8):1033-1046.
Go to original source... - Roux JP, Wegrzyn J, Boutroy S, Bouxsein ML, Hans D, Chapurlat R. The predictive value of trabecular bone score (TBS) on whole lum bar vertebrae mechanics: an ex vivo study. Osteoporos Int 2013;24(9): 2455-2460.
Go to original source... - Ferrar L, Jiang G, Adams J, Eastell R. Identification of vertebral tures: An update. Osteoporosis International 2005;16(7):717-728.
Go to original source... - Starup-Linde J, Vestergaard P. Biochemical bone turnover markers in diabetes mellitus - A systematic review. Bone 2016;82:69-78.
Go to original source... - Vestergaard P, Rejnmark L, Mosekilde L. Are antiresorptive drugs effective against fractures in patients with diabetes? Calcified tissue international 2011;88(3):209-214.
Go to original source... - Schwartz AV, Pavo I, Alam J, Disch DP, Schuster D, Harris JM et al. Teriparatide in patients with osteoporosis and type 2 diabetes. Bone 2016;91:152-158.
Go to original source...

